REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
05/16/2026
Back to search
Official data from USPTO
SENDERRA SPECIALTY PHARMACY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
05/17/2026
Trademark type
Combined
Nice classes
35
Filing date
09/30/2016
Registration date
05/16/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/07/2022
Last transaction
05/17/2026
Responsible office
United States Patent and Trademark Office
Status code
701
Official register
Principal Register
First use anywhere
01/19/2016
First use in commerce
01/19/2016
Drawing code
3
Owner type
16
Owner location
Dallas, TX, US
Examiner
KON, ELISSA GARBER
Law office
L60
Current location
TMEG LAW OFFICE 106
Mark description
The mark consists of the design of a green/blue incomplete circle with a portion curving to its upper right side, ending in a point, to the left of the stylized, gray word "SENDERRA" above the slanted green/blue wording "SPECIALTY PHARMACY."
Holders and representatives
Holders
Senderra Rx Partners, LLC
Representatives
Ann K. Ford DLA Piper LLP (US)
Technical classification
Nice Classes
Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Specialized retail pharmacy services for patients with particular medical conditions
Publications
History of USPTO decisions and trademark events.
24 publications found
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
09/07/2022
NA15
SEC. 15 ACKNOWLEDGEMENT - E-MAILED
09/07/2022
15AK
REGISTERED - SEC. 15 ACKNOWLEDGED
09/07/2022
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
09/07/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/07/2022
E15R
TEAS SECTION 15 RECEIVED
05/31/2022
ES8R
TEAS SECTION 8 RECEIVED
05/16/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/16/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/02/2018
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/02/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
05/16/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/28/2017
PUBO
PUBLISHED FOR OPPOSITION
02/28/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/08/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/11/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
01/11/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/11/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
01/11/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/11/2017
DOCK
ASSIGNED TO EXAMINER
01/10/2017
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
10/06/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/05/2016
NWAP
NEW APPLICATION ENTERED
10/04/2016
Continuous trademark protection
Get notified about every new filing that threatens SENDERRA SPECIALTY PHARMACY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.